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he most recent meta-analysis1 of 37 randomized tria
of off-pump coronary artery bypass (OPCAB) versus
conventional coronary artery bypass grafting (CABG)
demonstrated that mortality, stroke, myocardial infarc-
ion, and renal failure were not reduced in OPCAB; how
elected short-term and midterm clinical and resource outcomes
ere improved compared with CABG. The previous cumulative
nalysis (by Parolari and associates2) of 5 prospective randomiz
tudies (by Nathoe,3 Khan,4 Puskas,5 Widimsky,6 Lingaas,7 and
heir associates) then available in the literature, however, docu-
ented a reduction in postoperative patency of bypass grafts
erformed during OPCAB procedures. Since the meta-analysis by
arolari and associates2 was conducted, Lingaas and colleague8
ave updated the 3-month patency,7 and Kobayashi and cowork
rs9 and Al-Ruzzeh and associates10 have reported results of oth
andomized controlled trials. In these trials,8-10 OPCAB provided
he same angiographic graft patency as CABG, despite the con-
lusion of the meta-analysis by Parolari and colleagues.2 To reas-
ess differences in graft patency between OPCAB and CABG, we
erformed a meta-analysis of currently available randomized con-
rolled trials of OPCAB versus CABG.
aterials and Methods
ll prospective randomized controlled trials that compared pa-
ency at least 3 months after OPCAB and CABG were identified
sing a 2-level search strategy. First, a public domain database
MEDLINE) was searched with a Web-based search engine
PubMed). Second, relevant studies were identified through a
anual search of secondary sources including references of initially
dentified articles. The MEDLINE database was searched from Jan-
ary 1966 to June 2006. Keywords included “off-pump,” “off pump,”
opcab,” “patency,” and “randomized controlled trial.” Studies con-
idered for inclusion met the following criteria: The design was a
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2 The Journal of Thoracic and Cardiovascular Surgery ● Januarospective randomized controlled clinical trial; patients were ran-
omly assigned to OPCAB versus CABG; and main outcomes in-
luded at least 3-month graft patency evaluated by angiography. All
ualifying studies were assessed for adequate blinding of randomiza-
ion, completeness of follow-up, and objectivity of the outcome as-
essment. Data regarding arterial graft and venous graft (excluding
adial artery graft as available) patency were abstracted from each
ndividual study. For each study, data regarding patency in both the
PCAB and CABG groups were used to generate risk ratios (RRs)
1, favors OPCAB; 1, favors CABG) and risk differences (RDs)
0, favors OPCAB; 0, favors CABG) for graft “occlusion” and
5% confidence intervals (CIs). Study-specific estimates were com-
ined with a random-effect model. Between-study heterogeneity was
nalyzed by standard 2 tests. Sensitivity analyses were performed 
ssess the contribution of each study to the pooled estimate by
xcluding individual trials one at a time and recalculating the pooled
R and RD estimates for the remaining studies. Publication bias was
ssessed graphically with a funnel plot and mathematically with an
djusted rank-correlation test.
esults
ur search identified 6 prospective randomized controlled clinical
rials3-6,8,10 (Table 1). We excluded the trial by Kobayashi and 
iates9 because these workers merely examined early (within 3 w
fter the operation) graft patency. Allocation concealment and blind-
ng were not possible in these trials given that the intervention was
urgical; however, all trials used a blinded committee for adjudication
f events. Careful accounting for dropouts and crossovers was pro-
ided in all cases, and all but one analysis5 were conducted by
ntention-to-treat. All of the 6 individual trials demonstrated a statis-
ically nonsignificant benefit of CABG over OPCAB for overall graft
atency. Pooled analysis demonstrated a statistically significant 27%
ncrease in overall graft “occlusion” with OPCAB relative to CABG
RR, 1.27; 95% CI, 1.03-1.56; P  .0234) (RD, 3.0%; 95% CI,
.6%-5.4%; P  .0129). There was neither trial heterogeneity of
esults nor evidence of significant publication bias. Exclusion of any
ingle trial from the analysis did not substantively alter the overall
esult of our analysis. Subanalyses demonstrated a statistically non-
ignificant benefit of CABG over OPCAB for arterial graft patency
RR, 1.17; 95% CI, 0.62-2.24; P  .6259) (RD, 2.0%; 95% CI,
1.2%-5.2%; P .2195) and a statistically significant 28% increase
n venous graft “occlusion” with OPCAB relative to CABG (RR,
.28; 95% CI, 1.06-1.54; P  .0094) (RD, 4.0%; 95% CI, 0.2%-
.8%; P  .0396).
iscussion
he present meta-analysis demonstrated a significant increase in
verall graft “occlusion,” especially in venous graft “occlusion,”
ith OPCAB relative to CABG. On the one hand, OPCAB de-
ry 2007
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Brief Communicationsreases arterial fibrillation, transfusion, inotrope requirements, re-
piratory infections, ventilation time, intensive care unit stay, 
ospital stay.1 At the expense of graft patency, dare we per
PCAB rather than CABG to merely improve these selected
linical and resource outcomes?
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